» Articles » PMID: 22162707

L-carnitine Improves the Asthma Control in Children with Moderate Persistent Asthma

Overview
Date 2011 Dec 14
PMID 22162707
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The objective. was to investigate L-Carnitine level and the effects of its supplementation in children with moderate persistent Asthma. Methods. Free and total serum carnitine levels were measured in 50 children having moderate persistent asthma and 50 healthy control children. The patients group was randomly divided into two subgroups. Subgroup A was supplemented with L-carnitine for 6 months while subgroup B was used as a placebo controls. Both subgroups were assessed by pulmonary function tests (PFT) and childhood-asthma control test (C-ACT) before and 6 months after carnitine supplementation. Results. Total and free carnitine levels were significantly lower in patient group than in control group. PFT and C-ACT showed significant improvements in asthmatic children supplemented with L-carnitine than in those who were not supplemented. Conclusion. L-carnitine levels were initially lower in moderate persistent asthmatic children as compared to healthy control children. Asthmatic children who received L-carnitine supplementation showed statistically significant improvement of C-ACT and PFT.

Citing Articles

miRNAome-metabolome wide association study reveals effects of miRNA regulation in eosinophilia and airflow obstruction in childhood asthma.

Sharma R, Mendez K, Begum S, Chu S, Prince N, Hecker J EBioMedicine. 2024; 112:105534.

PMID: 39740296 PMC: 11750448. DOI: 10.1016/j.ebiom.2024.105534.


Phytotherapeutic BS012 and Its Active Component Ameliorate Allergic Asthma via Inhibition of Th2-Mediated Immune Response and Apoptosis.

Zhang S, Kim J, Lee G, Ahn H, Kim Y, Kim H Biomol Ther (Seoul). 2024; 32(6):744-758.

PMID: 39370723 PMC: 11535288. DOI: 10.4062/biomolther.2024.058.


Targeting Skeletal Muscle Dysfunction With L-Carnitine for the Treatment of Patients With Chronic Obstructive Pulmonary Disease.

Hoang B, Han B, Fang W, Nguyen A, Shaw D, Hoang C In Vivo. 2023; 37(4):1399-1411.

PMID: 37369514 PMC: 10347949. DOI: 10.21873/invivo.13224.


Exacerbation-prone pediatric asthma is associated with arginine, lysine, and methionine pathway alterations.

Cottrill K, Stephenson S, Mohammad A, Kim S, McCarty N, Kamaleswaran R J Allergy Clin Immunol. 2022; 151(1):118-127.e10.

PMID: 36096204 PMC: 9825634. DOI: 10.1016/j.jaci.2022.07.027.


Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches.

Yue L, Lu X, Dennery P, Yao H Redox Biol. 2021; 48:102104.

PMID: 34417157 PMC: 8710987. DOI: 10.1016/j.redox.2021.102104.


References
1.
Winter S, Curry C, HUTCHINSON H, Hogue R, Shug A . Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child. 1987; 141(6):660-5. DOI: 10.1001/archpedi.1987.04460060076039. View

2.
Devendra G, Spragg R . Lung surfactant in subacute pulmonary disease. Respir Res. 2002; 3:19. PMC: 107848. DOI: 10.1186/rr168. View

3.
Hallstrand T, Henderson Jr W . An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol. 2009; 10(1):60-6. PMC: 2838730. DOI: 10.1097/ACI.0b013e32833489c3. View

4.
Isaacs D, Joshi P . Respiratory infections and asthma. Med J Aust. 2002; 177(S6):S50-1. PMC: 7159118. DOI: 10.5694/j.1326-5377.2002.tb04816.x. View

5.
Miller M, Johnson C, Miller D, Deniz Y, Bleecker E, Wenzel S . Severity assessment in asthma: An evolving concept. J Allergy Clin Immunol. 2005; 116(5):990-5. DOI: 10.1016/j.jaci.2005.08.018. View